Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976
- PMID: 374644
- DOI: 10.1093/infdis/139.2.237
Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976
Abstract
Different rates of protection were observed in various groups of volunteers given trivalent subunit influenza virus vaccine during an epidemic caused by A/Victoria/3/75 strains of influenza virus in Melbourne, Victoria, Australia, in 1976. The degree of protection varied from 80% protection from infection in one group to a moderation in the severity of clinical illness in a geriatric group. The response to immunization may depend on the previous experience of the vaccinees, and it may be necessary to use different dose schedules in different groups for optimal protection.
Similar articles
-
Protection from natural infection after live influenza virus immunization in an open population.J Hyg (Lond). 1979 Apr;82(2):231-6. doi: 10.1017/s002217240002564x. J Hyg (Lond). 1979. PMID: 429787 Free PMC article. Clinical Trial.
-
[Seroconversion after vaccine with trivalent influenza vaccine during the epidemic season 1990/1 in Poland].Przegl Epidemiol. 1992;46(3):221-9. Przegl Epidemiol. 1992. PMID: 1296247 Polish.
-
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages.Vaccine. 2009 Jun 24;27(31):4099-103. doi: 10.1016/j.vaccine.2009.04.078. Epub 2009 May 14. Vaccine. 2009. PMID: 19410623
-
Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection.J Infect Dis. 1979 Dec;140(6):844-50. doi: 10.1093/infdis/140.6.844. J Infect Dis. 1979. PMID: 396336 Clinical Trial.
-
Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.Expert Rev Vaccines. 2012 Nov;11(11):1293-303. doi: 10.1586/erv.12.108. Epub 2012 Nov 14. Expert Rev Vaccines. 2012. PMID: 23151111 Review.
Cited by
-
Health Care-Acquired Viral Respiratory Diseases.Infect Dis Clin North Am. 2016 Dec;30(4):1053-1070. doi: 10.1016/j.idc.2016.07.004. Infect Dis Clin North Am. 2016. PMID: 27816139 Free PMC article. Review.
-
Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice.J Virol. 2004 Jul;78(14):7610-8. doi: 10.1128/JVI.78.14.7610-7618.2004. J Virol. 2004. PMID: 15220436 Free PMC article.
-
An outbreak of influenza A in a nursing home.Am J Public Health. 1986 May;76(5):501-4. doi: 10.2105/ajph.76.5.501. Am J Public Health. 1986. PMID: 3963278 Free PMC article.
-
Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation.Clin Exp Immunol. 1998 Nov;114(2):271-6. doi: 10.1046/j.1365-2249.1998.00714.x. Clin Exp Immunol. 1998. PMID: 9822287 Free PMC article.
-
Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.Clin Diagn Lab Immunol. 1996 Sep;3(5):511-6. doi: 10.1128/cdli.3.5.511-516.1996. Clin Diagn Lab Immunol. 1996. PMID: 8877127 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical